11-68403545-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002335.4(LRP5):​c.1647T>C​(p.Phe549Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.902 in 1,614,072 control chromosomes in the GnomAD database, including 659,627 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.84 ( 54985 hom., cov: 32)
Exomes 𝑓: 0.91 ( 604642 hom. )

Consequence

LRP5
NM_002335.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0750

Publications

47 publications found
Variant links:
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
LRP5 Gene-Disease associations (from GenCC):
  • bone mineral density quantitative trait locus 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • exudative vitreoretinopathy 4
    Inheritance: AD, SD, Unknown Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • osteoporosis-pseudoglioma syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant osteosclerosis, Worth type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • polycystic liver disease 4 with or without kidney cysts
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal dominant osteopetrosis 1
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • exudative vitreoretinopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyperostosis corticalis generalisata
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteosclerosis-developmental delay-craniosynostosis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polycystic liver disease 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 11-68403545-T-C is Benign according to our data. Variant chr11-68403545-T-C is described in ClinVar as Benign. ClinVar VariationId is 258634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.075 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.961 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002335.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP5
NM_002335.4
MANE Select
c.1647T>Cp.Phe549Phe
synonymous
Exon 8 of 23NP_002326.2
LRP5
NM_001291902.2
c.-291T>C
5_prime_UTR
Exon 7 of 23NP_001278831.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP5
ENST00000294304.12
TSL:1 MANE Select
c.1647T>Cp.Phe549Phe
synonymous
Exon 8 of 23ENSP00000294304.6
LRP5
ENST00000529993.5
TSL:1
n.*59T>C
non_coding_transcript_exon
Exon 7 of 23ENSP00000436652.1
LRP5
ENST00000529993.5
TSL:1
n.*59T>C
3_prime_UTR
Exon 7 of 23ENSP00000436652.1

Frequencies

GnomAD3 genomes
AF:
0.840
AC:
127718
AN:
152124
Hom.:
54955
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.633
Gnomad AMI
AF:
0.924
Gnomad AMR
AF:
0.889
Gnomad ASJ
AF:
0.895
Gnomad EAS
AF:
0.984
Gnomad SAS
AF:
0.927
Gnomad FIN
AF:
0.970
Gnomad MID
AF:
0.848
Gnomad NFE
AF:
0.912
Gnomad OTH
AF:
0.848
GnomAD2 exomes
AF:
0.906
AC:
227863
AN:
251440
AF XY:
0.911
show subpopulations
Gnomad AFR exome
AF:
0.625
Gnomad AMR exome
AF:
0.936
Gnomad ASJ exome
AF:
0.890
Gnomad EAS exome
AF:
0.989
Gnomad FIN exome
AF:
0.964
Gnomad NFE exome
AF:
0.910
Gnomad OTH exome
AF:
0.903
GnomAD4 exome
AF:
0.908
AC:
1327694
AN:
1461830
Hom.:
604642
Cov.:
67
AF XY:
0.910
AC XY:
661464
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.625
AC:
20928
AN:
33480
American (AMR)
AF:
0.932
AC:
41678
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.892
AC:
23313
AN:
26136
East Asian (EAS)
AF:
0.976
AC:
38753
AN:
39698
South Asian (SAS)
AF:
0.920
AC:
79373
AN:
86258
European-Finnish (FIN)
AF:
0.962
AC:
51383
AN:
53388
Middle Eastern (MID)
AF:
0.855
AC:
4929
AN:
5768
European-Non Finnish (NFE)
AF:
0.911
AC:
1013430
AN:
1111986
Other (OTH)
AF:
0.893
AC:
53907
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
7611
15222
22833
30444
38055
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21474
42948
64422
85896
107370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.839
AC:
127799
AN:
152242
Hom.:
54985
Cov.:
32
AF XY:
0.845
AC XY:
62913
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.633
AC:
26281
AN:
41506
American (AMR)
AF:
0.889
AC:
13609
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.895
AC:
3104
AN:
3470
East Asian (EAS)
AF:
0.984
AC:
5089
AN:
5172
South Asian (SAS)
AF:
0.927
AC:
4474
AN:
4826
European-Finnish (FIN)
AF:
0.970
AC:
10307
AN:
10622
Middle Eastern (MID)
AF:
0.844
AC:
248
AN:
294
European-Non Finnish (NFE)
AF:
0.912
AC:
62049
AN:
68026
Other (OTH)
AF:
0.849
AC:
1795
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
940
1881
2821
3762
4702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
878
1756
2634
3512
4390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.887
Hom.:
132401
Bravo
AF:
0.825
Asia WGS
AF:
0.926
AC:
3219
AN:
3478
EpiCase
AF:
0.908
EpiControl
AF:
0.908

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30747064)

Nov 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
2.2
DANN
Benign
0.61
PhyloP100
-0.075
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs545382; hg19: chr11-68171013; COSMIC: COSV53718067; COSMIC: COSV53718067; API